---
title: "BMS secures FDA acceptance for Camzyos sNDA"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288409479.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-06-02T10:14:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288409479.md)
  - [en](https://longbridge.com/en/news/288409479.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288409479.md)
---

# BMS secures FDA acceptance for Camzyos sNDA

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [Billionaire Izzy Englander Just Made a Big Bet on This Beaten-Down High-Yield Dividend Stock](https://longbridge.com/en/news/288895535.md)
- [FACTBOX-Major deals involving US drugmakers and biotechs over the past decade](https://longbridge.com/en/news/289163903.md)
- [Shift in biosimilar commercial landscape essential for sector sustainability, expert says](https://longbridge.com/en/news/289174897.md)
- [Parabilis eyes $475m IPO to push lead asset into Phase III](https://longbridge.com/en/news/288850252.md)
- [Incyte bolsters haematology portfolio in $2bn Vega buyout](https://longbridge.com/en/news/289087846.md)